Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
Tianxing Zhou, Yongjie Xie, Xupeng Hou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery
Wanfei Shao, Yanfang Yang, Weidong Shen, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132671-132671
Closed Access | Times Cited: 9
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
A fruitful century for the scalable synthesis and reactions of biphenyl derivatives: applications and biological aspects
Hajar A. Ali, Mohamed A. Ismail, A. S. Fouda, et al.
RSC Advances (2023) Vol. 13, Iss. 27, pp. 18262-18305
Open Access | Times Cited: 17
YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
Peixin Chen, Chenglong Sun, Hao Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 16
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Extracellular vesicles miR‐31‐5p promotes pancreatic cancer chemoresistance via regulating LATS2‐Hippo pathway and promoting SPARC secretion from pancreatic stellate cells
Cheng Qin, Bangbo Zhao, Yuanyang Wang, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 6
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer
Lukas Klein, Mengyu Tu, Niklas Krebs, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology
Jihao Xu, Minh Duc Pham, Vincenzo Corbo, et al.
Experimental & Molecular Medicine (2025)
Open Access
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Angiotensin system inhibitors improve survival in patients undergoing pancreatic cancer resection: a meta-analysis of real-world evidence
Yuxuan Lin, Yonghe Liao, Jinhai Shen
Expert Review of Anticancer Therapy (2025)
Closed Access
Microglia-derived CXCL2 induced neuronal ferroptosis via CXCR2/Jun axis in sepsis-associated encephalopathy
Yu-Shen Yang, Jin-Wei Liang, Meng-Qin Pei, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Silk Fibroin Nanoparticles for Enhanced Cuproptosis and Immunotherapy in Pancreatic Cancer Treatment
Si Gao, Heng Ge, Lili Gao, et al.
Advanced Science (2025)
Open Access
NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14
Ziyi Yang, Cheng Zhao, Shilei Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216703-216703
Open Access | Times Cited: 4
Epigenetic regulation of DNA repair gene program by Hippo/YAP1-TET1 axis mediates sorafenib resistance in HCC
Chunli Mo, Weixin You, Y. V. N. Rao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
A Two-Pronged Nanostrategy of Iron Metabolism Disruption to Synergize Tumor Therapy by Triggering the Paraptosis–Apoptosis Hybrid Pathway
Huali Lei, Guanghui Hou, Lin Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 33, pp. 22257-22274
Closed Access | Times Cited: 4
OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression
Wenjie Zhu, Changlei Wu, Zitao Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Knockdown of LAMA3 enhances the sensitivity of colon cancer to oxaliplatin by regulating the Hippo-YAP pathway
Jiqiang Li, Ya‐Hui Yu, Rong Zeng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167665-167665
Closed Access
Emerging roles of 3D-culture systems in tackling tumor drug resistance
Amin Nikdouz, Francesca Orso
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 788-804
Open Access | Times Cited: 9
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 3
DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review
Xin Fu, Zhaosong Wang
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems
Giulia Lencioni, Alessandro Gregori, Belen Toledo B, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 3
YAP1 affects the prognosis through the regulation of stemness in endometrial cancer
Wei Kong, Yuzhen Huang, Peng Jiang, et al.
PeerJ (2023) Vol. 11, pp. e15891-e15891
Open Access | Times Cited: 5
Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway
Wenna Yu, Fuling Zeng, Yang Xiao, et al.
Chemico-Biological Interactions (2023) Vol. 387, pp. 110816-110816
Closed Access | Times Cited: 4
Jian-Pi-Gu-Shen-Hua-Yu Decoction Alleviated Diabetic Nephropathy in Mice through Reducing Ferroptosis
Shuquan Lv, Lirong Fan, Xiaoting Chen, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top